Answers are grounded in this paper and cite their sources.
The Visitect CD4 Advanced Disease test (AccuBio, Alva, United Kingdom) is a rapid, semi-quantitative assay that estimates CD4 results above or below 200 cells/μL. We evaluated the performance of the Visitect CD4 assay in semi-urban laboratories in Uganda.
No takes yet. Share an insight, caveat, or question.
Nalintya et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: